• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤中剪接因子-SRSF3的异常表达及调控网络

Aberrant expression and regulatory network of splicing factor-SRSF3 in tumors.

作者信息

Che Yingying, Fu Lin

机构信息

Institute of Chronic Disease, Qingdao Municipal Hospital, Qingdao University, Qingdao 266000, China.

出版信息

J Cancer. 2020 Mar 15;11(12):3502-3511. doi: 10.7150/jca.42645. eCollection 2020.

DOI:10.7150/jca.42645
PMID:32284746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7150454/
Abstract

Alternative splicing facilitates the splicing of precursor RNA into different isoforms. Alternatively spliced transcripts often exhibit antagonistic functions or differential temporal or spatial expression patterns. There is increasing evidence that alternative splicing, especially by the serine-arginine rich (SR) protein family, leads to abnormal expression patterns and is closely related to the development of cancer. SRSF3, also known as SRp20, is a splicing factor. Through alternative splicing, it plays important roles in regulating various biological functions, such as cell cycle, cell proliferation, migration and invasion, under pathological and physiological conditions. Deregulation of SRSF3 is an essential feature of cancers. SRSF3 is also considered a candidate therapeutic target. Therefore, the involvement of abnormal splicing in tumorigenesis and the regulation of splicing factors deserve further analysis and discussion. Here, we summarize the function of SRSF3-regulated alternative transcripts in cancer cell biology at different stages of tumor development and the regulation of SRSF3 in tumorigenesis.

摘要

可变剪接有助于将前体RNA剪接成不同的异构体。可变剪接的转录本通常表现出拮抗功能或不同的时空表达模式。越来越多的证据表明,可变剪接,尤其是富含丝氨酸-精氨酸(SR)的蛋白质家族介导的可变剪接,会导致异常的表达模式,并且与癌症的发生密切相关。SRSF3,也称为SRp20,是一种剪接因子。通过可变剪接,它在病理和生理条件下调节各种生物学功能,如细胞周期、细胞增殖、迁移和侵袭等方面发挥重要作用。SRSF3失调是癌症的一个重要特征。SRSF3也被认为是一个候选治疗靶点。因此,异常剪接在肿瘤发生中的作用以及剪接因子的调控值得进一步分析和讨论。在这里,我们总结了SRSF3调控的可变转录本在肿瘤发展不同阶段的癌细胞生物学中的功能以及SRSF3在肿瘤发生中的调控作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697a/7150454/d6bfb6170bb0/jcav11p3502g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697a/7150454/78764f33c38b/jcav11p3502g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697a/7150454/d6bfb6170bb0/jcav11p3502g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697a/7150454/78764f33c38b/jcav11p3502g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697a/7150454/d6bfb6170bb0/jcav11p3502g002.jpg

相似文献

1
Aberrant expression and regulatory network of splicing factor-SRSF3 in tumors.肿瘤中剪接因子-SRSF3的异常表达及调控网络
J Cancer. 2020 Mar 15;11(12):3502-3511. doi: 10.7150/jca.42645. eCollection 2020.
2
Biological function and molecular mechanism of SRSF3 in cancer and beyond.SRSF3在癌症及其他方面的生物学功能和分子机制。
Oncol Lett. 2022 Jan;23(1):21. doi: 10.3892/ol.2021.13139. Epub 2021 Nov 16.
3
Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.剪接因子 SRSF3 的下调诱导 p53β 的产生,p53β 是 p53 的一种选择性剪接异构体,能促进细胞衰老。
Oncogene. 2013 May 30;32(22):2792-8. doi: 10.1038/onc.2012.288. Epub 2012 Jul 9.
4
SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.SRSF5 作为一种新型致癌剪接因子,可被口腔鳞状细胞癌中的致癌基因 SRSF3 上调。
Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1161-1172. doi: 10.1016/j.bbamcr.2018.05.017. Epub 2018 May 30.
5
Construction and evaluation of an adenoviral vector for the liver-specific expression of the serine/arginine-rich splicing factor, SRSF3.用于肝脏特异性表达富含丝氨酸/精氨酸剪接因子SRSF3的腺病毒载体的构建与评价
Plasmid. 2015 Nov;82:1-9. doi: 10.1016/j.plasmid.2015.07.004. Epub 2015 Aug 1.
6
SRSF3 represses the expression of PDCD4 protein by coordinated regulation of alternative splicing, export and translation.SRSF3通过对可变剪接、输出和翻译的协同调控来抑制PDCD4蛋白的表达。
Biochem Biophys Res Commun. 2016 Feb 5;470(2):431-438. doi: 10.1016/j.bbrc.2016.01.019. Epub 2016 Jan 8.
7
SRSF3 suppresses RCC tumorigenesis and progression via regulating SP4 alternative splicing.SRSF3 通过调控 SP4 可变剪接抑制肾透明细胞癌的发生发展。
Biochim Biophys Acta Mol Cell Res. 2024 Dec;1871(8):119841. doi: 10.1016/j.bbamcr.2024.119841. Epub 2024 Aug 31.
8
Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.剪接因子SRSF3通过调控DDX5促进宫颈癌进展。
Mol Carcinog. 2023 Feb;62(2):210-223. doi: 10.1002/mc.23477. Epub 2022 Oct 25.
9
A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells.人骨肉瘤U2OS细胞中SRSF3调控的剪接事件和基因表达的基因组图谱。
Nucleic Acids Res. 2016 Feb 29;44(4):1854-70. doi: 10.1093/nar/gkv1500. Epub 2015 Dec 23.
10
Oncogenic SRSF3 in health and diseases.致癌性 SRSF3 在健康与疾病中的作用。
Int J Biol Sci. 2023 Jun 12;19(10):3057-3076. doi: 10.7150/ijbs.83368. eCollection 2023.

引用本文的文献

1
Splicing factor PTBP1 promotes hepatocarcinogenesis via oncogenic splice-switching of MAPT.剪接因子PTBP1通过MAPT的致癌性剪接转换促进肝癌发生。
Oncol Res. 2025 Apr 18;33(5):1121-1133. doi: 10.32604/or.2025.060958. eCollection 2025.
2
Tumor-promoting effect and tumor immunity of SRSFs.丝氨酸/精氨酸丰富剪接因子(SRSFs)的促肿瘤作用及肿瘤免疫
Front Cell Dev Biol. 2025 Mar 10;13:1527309. doi: 10.3389/fcell.2025.1527309. eCollection 2025.
3
Bioinformatics and assays identified miR-486-5p as a tumor suppressor miRNA in hepatocellular carcinoma.

本文引用的文献

1
SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.SRSF3 调控的 RNA 可变剪接通过影响多种细胞过程促进神经胶质瘤的肿瘤发生。
Cancer Res. 2019 Oct 15;79(20):5288-5301. doi: 10.1158/0008-5472.CAN-19-1504. Epub 2019 Aug 28.
2
Degradation of splicing factor SRSF3 contributes to progressive liver disease.剪接因子 SRSF3 的降解导致进行性肝病。
J Clin Invest. 2019 Aug 8;129(10):4477-4491. doi: 10.1172/JCI127374.
3
Cortisol-induced SRSF3 expression promotes GR splicing, RACK1 expression and breast cancer cells migration.
生物信息学和实验鉴定出miR-486-5p是肝细胞癌中的一种肿瘤抑制性微小RNA。
Heliyon. 2024 Oct 29;10(24):e39909. doi: 10.1016/j.heliyon.2024.e39909. eCollection 2024 Dec 30.
4
Development of DNA Insertion-specific Markers Based on the Intergenic Region of Oplegnathus punctatus Cdkn1/srsf3 for Sex Identification.基于 Oplegnathus punctatus Cdkn1/srsf3 基因间区开发的 DNA 插入特异性标记物用于性别鉴定。
Mar Biotechnol (NY). 2024 Aug;26(4):687-695. doi: 10.1007/s10126-024-10336-6. Epub 2024 Jun 14.
5
Circular RNA hsa_circ_0050386 suppresses non-small cell lung cancer progression via regulating the SRSF3/FN1 axis.环状 RNA hsa_circ_0050386 通过调控 SRSF3/FN1 轴抑制非小细胞肺癌进展。
J Transl Med. 2024 Jan 12;22(1):47. doi: 10.1186/s12967-023-04812-1.
6
The role of alternative pre-mRNA splicing in cancer progression.可变前体信使核糖核酸剪接在癌症进展中的作用。
Cancer Cell Int. 2023 Oct 24;23(1):249. doi: 10.1186/s12935-023-03094-3.
7
An Improved Model for Circular RNA Overexpression: Using the Actin Intron Reveals High Circularization Efficiency.一种用于环状RNA过表达的改进模型:利用肌动蛋白内含子显示出高环化效率。
Adv Genet (Hoboken). 2022 Oct 9;4(3):2200019. doi: 10.1002/ggn2.202200019. eCollection 2023 Sep.
8
Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths.单细胞多组学定义了剪接异常对人类造血克隆性生长的细胞类型特异性影响。
Cell Stem Cell. 2023 Sep 7;30(9):1262-1281.e8. doi: 10.1016/j.stem.2023.07.012. Epub 2023 Aug 14.
9
SRSF3 Restriction Eases Cervical Cancer Cell Viability and Metastasis via Adjusting PI3K/AKT/mTOR Signaling Pathway.SRSF3 通过调节 PI3K/AKT/mTOR 信号通路促进宫颈癌癌细胞的活力和转移。
Contrast Media Mol Imaging. 2022 Sep 26;2022:8497078. doi: 10.1155/2022/8497078. eCollection 2022.
10
Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.肝细胞中 IGF2 的缺失可预防肝癌中的 DNA 损伤和肿瘤形成。
Adv Sci (Weinh). 2022 Jul;9(21):e2105120. doi: 10.1002/advs.202105120. Epub 2022 May 26.
皮质醇诱导的 SRSF3 表达促进 GR 剪接、RACK1 表达和乳腺癌细胞迁移。
Pharmacol Res. 2019 May;143:17-26. doi: 10.1016/j.phrs.2019.03.008. Epub 2019 Mar 9.
4
Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.致癌剪接因子 SRSF3 通过调节 ILF3 的可变剪接促进癌细胞增殖和转化。
RNA. 2019 May;25(5):630-644. doi: 10.1261/rna.068619.118. Epub 2019 Feb 22.
5
Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins.剪接事件在基因组完整性控制中的作用:SLU7 和截断 SRSF3 蛋白的作用。
Nucleic Acids Res. 2019 Apr 23;47(7):3450-3466. doi: 10.1093/nar/gkz014.
6
Distinct mechanisms govern the phosphorylation of different SR protein splicing factors.不同的 SR 蛋白剪接因子的磷酸化由不同的机制控制。
J Biol Chem. 2019 Jan 25;294(4):1312-1327. doi: 10.1074/jbc.RA118.003392. Epub 2018 Nov 26.
7
SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.SRSF3,PKM 基因的剪接体,调节结肠癌细胞的细胞生长和特定于癌症的能量代谢的维持。
Int J Mol Sci. 2018 Oct 2;19(10):3012. doi: 10.3390/ijms19103012.
8
A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway.一个包含卷曲螺旋结构域的 50 号剪接变异体受富含丝氨酸/精氨酸的剪接因子 3 的调节,并通过 Ras 信号通路促进小鼠肝癌的发生。
Hepatology. 2019 Jan;69(1):179-195. doi: 10.1002/hep.30147. Epub 2018 Dec 22.
9
Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth.剪接因子 SRSF5 的乙酰化和泛素化相互排斥,控制肿瘤生长。
Nat Commun. 2018 Jun 25;9(1):2464. doi: 10.1038/s41467-018-04815-3.
10
Cdk1 phosphorylation of the dynein adapter Nde1 controls cargo binding from G2 to anaphase.Cdk1 对动力蛋白适配器 Nde1 的磷酸化控制了货物从 G2 期到后期的结合。
J Cell Biol. 2018 Sep 3;217(9):3019-3029. doi: 10.1083/jcb.201707081. Epub 2018 Jun 21.